Hannah Gilman

1.7k total citations · 1 hit paper
22 papers, 792 citations indexed

About

Hannah Gilman is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hannah Gilman has authored 22 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 10 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hannah Gilman's work include Cancer Immunotherapy and Biomarkers (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cardiac tumors and thrombi (5 papers). Hannah Gilman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Cardiac tumors and thrombi (5 papers). Hannah Gilman collaborates with scholars based in United States, Hungary and Germany. Hannah Gilman's co-authors include Zsófia D. Drobni, Tomas G. Neilan, Amna Zafar, Daniel A. Zlotoff, Sarah Hartmann, Raza M. Alvi, Kerry L. Reynolds, Ryan J. Sullivan, Jingyi Gong and Leyre Zubiri and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Hannah Gilman

19 papers receiving 781 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque

2020 356 citations Zsófia D. Drobni, Raza M. Alvi et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannah Gilman United States	11	485	393	154	120	104	22	792
Sarah Hartmann Hungary	8	424 0.9×	363 0.9×	132 0.9×	103 0.9×	96 0.9×	9	696
Anne‐Flore Plane France	6	479 1.0×	178 0.5×	168 1.1×	99 0.8×	63 0.6×	13	656
Rümeysa Çiftçi Türkiye	16	385 0.8×	136 0.3×	249 1.6×	43 0.4×	134 1.3×	43	776
Maria Laura Canale Italy	15	204 0.4×	551 1.4×	209 1.4×	45 0.4×	175 1.7×	77	895
Simone M. Mrotzek Germany	10	174 0.4×	222 0.6×	66 0.4×	86 0.7×	80 0.8×	15	414
Angélique Da Silva France	7	451 0.9×	98 0.2×	176 1.1×	86 0.7×	51 0.5×	19	580
Mustafa Dikilitaş Türkiye	12	327 0.7×	221 0.6×	210 1.4×	17 0.1×	107 1.0×	39	600
Charlene Mantia United States	13	281 0.6×	98 0.2×	244 1.6×	55 0.5×	126 1.2×	52	657
Xianchun Meng China	10	308 0.6×	88 0.2×	88 0.6×	83 0.7×	229 2.2×	14	726
Vasile Foris Austria	18	136 0.3×	341 0.9×	786 5.1×	85 0.7×	162 1.6×	54	1.1k

Countries citing papers authored by Hannah Gilman

Since Specialization

Citations

This map shows the geographic impact of Hannah Gilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Gilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Gilman more than expected).

Fields of papers citing papers by Hannah Gilman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Gilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Gilman. The network helps show where Hannah Gilman may publish in the future.

Co-authorship network of co-authors of Hannah Gilman

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Gilman. A scholar is included among the top collaborators of Hannah Gilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Gilman. Hannah Gilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suero‐Abreu, Giselle Alexandra, Zsófia D. Drobni, Carlos A. Gongora, et al.. (2025). Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer. Journal of the American Heart Association. 15(6). e041925–e041925. 1 indexed citations

Drobni, Zsófia D., Thiago Quinaglia, Hannah Gilman, et al.. (2025). Atorvastatin and left atrial function during anthracycline-based chemotherapy. Journal of Cardiovascular Magnetic Resonance. 27(2). 101946–101946.

Drobni, Zsófia D., Thiago Quinaglia, Hannah Gilman, et al.. (2025). Atorvastatin and Aortic Stiffness During Anthracycline-Based Chemotherapy. JAMA Cardiology. 11(1). 68–68.

Quinaglia, Thiago, Jessie P. Bakker, Dimitrios Baltzis, et al.. (2025). Effect of continuous positive airway pressure on ventricular remodeling of patients with combined diabetes mellitus and obstructive sleep apnea: a cross-sectional study and follow-on randomized clinical trial. International Journal of Cardiology. 441. 133788–133788.

Sun, Virginia, Vineet K. Raghu, Chia‐Yun Wu, et al.. (2024). Abstract 4119426: Enhancing early detection of ICI myocarditis cases during hospitalization: A role for large language models. Circulation. 150(Suppl_1). 1 indexed citations

Quinaglia, Thiago, Zsófia D. Drobni, Jennifer E. Ho, et al.. (2023). Atrial and ventricular arrhythmias with immune checkpoint inhibitor therapy in patients without evidence of myocarditis. European Heart Journal. 44(Supplement_2). 3 indexed citations

Drobni, Zsófia D., Carlos A. Gongora, Jana Taron, et al.. (2023). Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer. Journal for ImmunoTherapy of Cancer. 11(7). e007307–e007307. 31 indexed citations

Suero‐Abreu, Giselle Alexandra, Zsófia D. Drobni, Carlos A. Gongora, et al.. (2023). ASSOCIATION BETWEEN IMMUNE CHECKPOINT INHIBITORS WITH ATHEROSCLEROTIC PLAQUE PROGRESSION AND CARDIOVASCULAR EVENTS IN FEMALE PATIENTS WITH CANCER. Journal of the American College of Cardiology. 81(8). 2127–2127. 1 indexed citations

Drobni, Zsófia D., Olivier Michielin, Thiago Quinaglia, et al.. (2022). Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors. European Journal of Cancer. 163. 108–118. 28 indexed citations

10.

Zafar, Amna, Zsófia D. Drobni, Carlos A. Gongora, et al.. (2022). The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm. PLoS ONE. 17(4). e0265767–e0265767. 14 indexed citations

11.

Gongora, Carlos A., Zsófia D. Drobni, Amna Zafar, et al.. (2022). Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines. JACC Heart Failure. 10(8). 559–567. 97 indexed citations

12.

Hassan, Malek, Magid Awadalla, Timothy C. Tan, et al.. (2022). Serial Measurement of Global Longitudinal Strain Among Women With Breast Cancer Treated With Proton Radiation Therapy: A Prospective Trial for 70 Patients. International Journal of Radiation Oncology*Biology*Physics. 115(2). 398–406. 10 indexed citations

13.

Alvi, Raza M., Thiago Quinaglia, Aferdita Spahillari, et al.. (2022). The Prediction of Cardiac Events Using Contemporary Risk Prediction Models after Radiation Therapy for Head and Neck Cancer. Cancers. 14(15). 3651–3651. 3 indexed citations

14.

Zafar, Amna, Zsófia D. Drobni, Ramya Mosarla, et al.. (2021). The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm. JACC CardioOncology. 3(1). 101–109. 47 indexed citations

15.

Gong, Jingyi, Zsófia D. Drobni, Raza M. Alvi, et al.. (2021). Immune checkpoint inhibitors for cancer and venous thromboembolic events. European Journal of Cancer. 158. 99–110. 62 indexed citations

16.

Drobni, Zsófia D., Sean Murphy, Raza M. Alvi, et al.. (2021). Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors. PubMed. 1(1). ltab014–ltab014. 19 indexed citations

17.

Gong, Jingyi, Zsófia D. Drobni, Amna Zafar, et al.. (2021). Pericardial disease in patients treated with immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 9(6). e002771–e002771. 58 indexed citations

18.

Drobni, Zsófia D., Amna Zafar, Leyre Zubiri, et al.. (2020). Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis. Journal of the American Heart Association. 9(23). e018306–e018306. 54 indexed citations

19.

Gong, Jingyi, Zsófia D. Drobni, Raza M. Alvi, et al.. (2020). Abstract 15395: Immune Checkpoint Inhibitors for Cancer Are Associated With Increased Venous Thromboembolism Events. Circulation. 142(Suppl_3). 1 indexed citations

20.

Drobni, Zsófia D., Raza M. Alvi, Jana Taron, et al.. (2020). Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque. Circulation. 142(24). 2299–2311. 356 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact